1. Home
  2. INCY vs MTD Comparison

INCY vs MTD Comparison

Compare INCY & MTD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Incyte Corp.

INCY

Incyte Corp.

N/A

Current Price

$114.90

Market Cap

24.5B

Sector

Health Care

ML Signal

N/A

Logo Mettler-Toledo International Inc.

MTD

Mettler-Toledo International Inc.

N/A

Current Price

$1,675.74

Market Cap

28.6B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
INCY
MTD
Founded
1991
1991
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Biotechnology: Commercial Physical & Biological Resarch
Biotechnology: Laboratory Analytical Instruments
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
24.5B
28.6B
IPO Year
1994
1997

Fundamental Metrics

Financial Performance
Metric
INCY
MTD
Price
$114.90
$1,675.74
Analyst Decision
Buy
Hold
Analyst Count
28
13
Target Price
$132.17
★ $1,737.50
AVG Volume (30 Days)
★ 1.5M
156.4K
Earning Date
10-29-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 4173.33
3.88
EPS
0.50
★ 32.14
Revenue
$3,394,635,000.00
★ $4,026,399,000.00
Revenue This Year
$17.74
$5.90
Revenue Next Year
$4.38
$4.38
P/E Ratio
$231.80
★ $53.07
Revenue Growth
★ 13.67
3.98
52 Week Low
$89.25
$1,023.05
52 Week High
$132.60
$1,806.58

Technical Indicators

Market Signals
Indicator
INCY
MTD
Relative Strength Index (RSI) 41.81 48.90
Support Level $109.78 $1,239.25
Resistance Level $119.29 $1,806.58
Average True Range (ATR) 3.73 48.76
MACD -0.53 -12.35
Stochastic Oscillator 3.94 4.76

Price Performance

Historical Comparison
INCY
MTD

About INCY Incyte Corp.

Incyte focuses on the discovery and development of small-molecule drugs. The firm's leading drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis and 2022 for vitiligo. Incyte's pipeline includes an array of oncology and dermatology programs.

About MTD Mettler-Toledo International Inc.

Mettler-Toledo supplies weighing and precision instruments to customers in the life sciences (around 55% of sales), industrial (around 40%), and food retail (around 5%) industries. Its products include laboratory and retail scales, pipettes, pH meters, thermal analysis equipment, titrators, metal detectors, and X-ray analyzers. Mettler leads the market for weighing instrumentation and controls more than 50% of the market for lab balances. The business is geographically diversified, with the Americas accounting for about 37% of sales, Europe about 27%, China about 16% and the rest of the world about 20%.

Share on Social Networks: